Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion
- Autores
- Aquino, Marilín Estefanía; Drago, Silvina Rosa; Sánchez de Medina, Fermín; Martínez Augustin, Olga; Cian, Raúl Esteban
- Año de publicación
- 2024
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Brewer´s spent yeast (BSY) hydrolysates are a source of antidiabetic peptides. Nevertheless, the impact of in vitro gastrointestinal digestion of BSY derived peptides on diabetes has not been assessed. In this study, two BSY hydrolysates were obtained (H1 and H2) using β-glucanase and alkaline protease, with either 1 h or 2 h hydrolysis time for H1 and H2, respectively. These hydrolysates were then subjected to simulated gastrointestinal digestion (SGID), obtaining dialysates D1 and D2, respectively. BSY hydrolysates inhibited the activity of α-glucosidase and dipeptidyl peptidase IV (DPP-IV) enzymes. Moreover, although D2 was inactive against these enzymes, D1 IC50 value was lower than those found for the hydrolysates. Interestingly, after electrophoretic separation, D1 mannose-linked peptides showed the highest α-glucosidase inhibitory activity, while non-glycosylated peptides had the highest DPP-IV inhibitory activity. Kinetic analyses showed a non-competitive mechanism in both cases. After peptide identification, GILFVGSGVSGGEEGAR and IINEPTAAAIAYGLDK showed the highest in silico anti-diabetic activities among mannose-linked and non-glycosylated peptides, respectively (AntiDMPpred score: 0.70 and 0.77). Molecular docking also indicated that these peptides act as non-competitive inhibitors. Finally, an ex vivo model of mouse jejunum organoids was used to study the effect of D1 on the expression of intestinal epithelial genes related to diabetes. The reduction of the expression of genes that codify lactase, sucrase-isomaltase and glucose transporter 2 was observed, as well as an increase in the expression of Gip (glucose-dependent insulinotropic peptide) and Glp1 (glucagon-like peptide 1). This is the first report to evaluate the anti-diabetic effect of BSY peptides in mouse jejunum organoids.
Fil: Aquino, Marilín Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina
Fil: Drago, Silvina Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina
Fil: Sánchez de Medina, Fermín. Universidad de Granada. Facultad de Farmacia.; España
Fil: Martínez Augustin, Olga. Universidad de Granada. Facultad de Farmacia.; España
Fil: Cian, Raúl Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina - Materia
-
ANTI-DIABETIC PROPERTIES
BREWER'S SPENT YEAST PEPTIDES
SIMULATED GASTROINTESTINAL DIGESTION
MOUSE JEJUNUM ORGANOIDS - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- https://creativecommons.org/licenses/by-nc/2.5/ar/
- Repositorio
- Institución
- Consejo Nacional de Investigaciones Científicas y Técnicas
- OAI Identificador
- oai:ri.conicet.gov.ar:11336/233450
Ver los metadatos del registro completo
id |
CONICETDig_350cbda2023233fc6d7581ab559f72b1 |
---|---|
oai_identifier_str |
oai:ri.conicet.gov.ar:11336/233450 |
network_acronym_str |
CONICETDig |
repository_id_str |
3498 |
network_name_str |
CONICET Digital (CONICET) |
spelling |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestionAquino, Marilín EstefaníaDrago, Silvina RosaSánchez de Medina, FermínMartínez Augustin, OlgaCian, Raúl EstebanANTI-DIABETIC PROPERTIESBREWER'S SPENT YEAST PEPTIDESSIMULATED GASTROINTESTINAL DIGESTIONMOUSE JEJUNUM ORGANOIDShttps://purl.org/becyt/ford/1.6https://purl.org/becyt/ford/1Brewer´s spent yeast (BSY) hydrolysates are a source of antidiabetic peptides. Nevertheless, the impact of in vitro gastrointestinal digestion of BSY derived peptides on diabetes has not been assessed. In this study, two BSY hydrolysates were obtained (H1 and H2) using β-glucanase and alkaline protease, with either 1 h or 2 h hydrolysis time for H1 and H2, respectively. These hydrolysates were then subjected to simulated gastrointestinal digestion (SGID), obtaining dialysates D1 and D2, respectively. BSY hydrolysates inhibited the activity of α-glucosidase and dipeptidyl peptidase IV (DPP-IV) enzymes. Moreover, although D2 was inactive against these enzymes, D1 IC50 value was lower than those found for the hydrolysates. Interestingly, after electrophoretic separation, D1 mannose-linked peptides showed the highest α-glucosidase inhibitory activity, while non-glycosylated peptides had the highest DPP-IV inhibitory activity. Kinetic analyses showed a non-competitive mechanism in both cases. After peptide identification, GILFVGSGVSGGEEGAR and IINEPTAAAIAYGLDK showed the highest in silico anti-diabetic activities among mannose-linked and non-glycosylated peptides, respectively (AntiDMPpred score: 0.70 and 0.77). Molecular docking also indicated that these peptides act as non-competitive inhibitors. Finally, an ex vivo model of mouse jejunum organoids was used to study the effect of D1 on the expression of intestinal epithelial genes related to diabetes. The reduction of the expression of genes that codify lactase, sucrase-isomaltase and glucose transporter 2 was observed, as well as an increase in the expression of Gip (glucose-dependent insulinotropic peptide) and Glp1 (glucagon-like peptide 1). This is the first report to evaluate the anti-diabetic effect of BSY peptides in mouse jejunum organoids.Fil: Aquino, Marilín Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; ArgentinaFil: Drago, Silvina Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; ArgentinaFil: Sánchez de Medina, Fermín. Universidad de Granada. Facultad de Farmacia.; EspañaFil: Martínez Augustin, Olga. Universidad de Granada. Facultad de Farmacia.; EspañaFil: Cian, Raúl Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; ArgentinaRoyal Society of Chemistry2024-03info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/233450Aquino, Marilín Estefanía; Drago, Silvina Rosa; Sánchez de Medina, Fermín; Martínez Augustin, Olga; Cian, Raúl Esteban; Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion; Royal Society of Chemistry; Food & Function; 15; 7; 3-2024; 3778-37902042-64962042-650XCONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/url/https://pubs.rsc.org/en/content/articlelanding/2024/fo/d3fo04040binfo:eu-repo/semantics/altIdentifier/doi/10.1039/D3FO04040Binfo:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T10:03:33Zoai:ri.conicet.gov.ar:11336/233450instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 10:03:33.449CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse |
dc.title.none.fl_str_mv |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
title |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
spellingShingle |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion Aquino, Marilín Estefanía ANTI-DIABETIC PROPERTIES BREWER'S SPENT YEAST PEPTIDES SIMULATED GASTROINTESTINAL DIGESTION MOUSE JEJUNUM ORGANOIDS |
title_short |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
title_full |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
title_fullStr |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
title_full_unstemmed |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
title_sort |
Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion |
dc.creator.none.fl_str_mv |
Aquino, Marilín Estefanía Drago, Silvina Rosa Sánchez de Medina, Fermín Martínez Augustin, Olga Cian, Raúl Esteban |
author |
Aquino, Marilín Estefanía |
author_facet |
Aquino, Marilín Estefanía Drago, Silvina Rosa Sánchez de Medina, Fermín Martínez Augustin, Olga Cian, Raúl Esteban |
author_role |
author |
author2 |
Drago, Silvina Rosa Sánchez de Medina, Fermín Martínez Augustin, Olga Cian, Raúl Esteban |
author2_role |
author author author author |
dc.subject.none.fl_str_mv |
ANTI-DIABETIC PROPERTIES BREWER'S SPENT YEAST PEPTIDES SIMULATED GASTROINTESTINAL DIGESTION MOUSE JEJUNUM ORGANOIDS |
topic |
ANTI-DIABETIC PROPERTIES BREWER'S SPENT YEAST PEPTIDES SIMULATED GASTROINTESTINAL DIGESTION MOUSE JEJUNUM ORGANOIDS |
purl_subject.fl_str_mv |
https://purl.org/becyt/ford/1.6 https://purl.org/becyt/ford/1 |
dc.description.none.fl_txt_mv |
Brewer´s spent yeast (BSY) hydrolysates are a source of antidiabetic peptides. Nevertheless, the impact of in vitro gastrointestinal digestion of BSY derived peptides on diabetes has not been assessed. In this study, two BSY hydrolysates were obtained (H1 and H2) using β-glucanase and alkaline protease, with either 1 h or 2 h hydrolysis time for H1 and H2, respectively. These hydrolysates were then subjected to simulated gastrointestinal digestion (SGID), obtaining dialysates D1 and D2, respectively. BSY hydrolysates inhibited the activity of α-glucosidase and dipeptidyl peptidase IV (DPP-IV) enzymes. Moreover, although D2 was inactive against these enzymes, D1 IC50 value was lower than those found for the hydrolysates. Interestingly, after electrophoretic separation, D1 mannose-linked peptides showed the highest α-glucosidase inhibitory activity, while non-glycosylated peptides had the highest DPP-IV inhibitory activity. Kinetic analyses showed a non-competitive mechanism in both cases. After peptide identification, GILFVGSGVSGGEEGAR and IINEPTAAAIAYGLDK showed the highest in silico anti-diabetic activities among mannose-linked and non-glycosylated peptides, respectively (AntiDMPpred score: 0.70 and 0.77). Molecular docking also indicated that these peptides act as non-competitive inhibitors. Finally, an ex vivo model of mouse jejunum organoids was used to study the effect of D1 on the expression of intestinal epithelial genes related to diabetes. The reduction of the expression of genes that codify lactase, sucrase-isomaltase and glucose transporter 2 was observed, as well as an increase in the expression of Gip (glucose-dependent insulinotropic peptide) and Glp1 (glucagon-like peptide 1). This is the first report to evaluate the anti-diabetic effect of BSY peptides in mouse jejunum organoids. Fil: Aquino, Marilín Estefanía. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina Fil: Drago, Silvina Rosa. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina Fil: Sánchez de Medina, Fermín. Universidad de Granada. Facultad de Farmacia.; España Fil: Martínez Augustin, Olga. Universidad de Granada. Facultad de Farmacia.; España Fil: Cian, Raúl Esteban. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Ingeniería Química. Instituto de Tecnología de los Alimentos; Argentina |
description |
Brewer´s spent yeast (BSY) hydrolysates are a source of antidiabetic peptides. Nevertheless, the impact of in vitro gastrointestinal digestion of BSY derived peptides on diabetes has not been assessed. In this study, two BSY hydrolysates were obtained (H1 and H2) using β-glucanase and alkaline protease, with either 1 h or 2 h hydrolysis time for H1 and H2, respectively. These hydrolysates were then subjected to simulated gastrointestinal digestion (SGID), obtaining dialysates D1 and D2, respectively. BSY hydrolysates inhibited the activity of α-glucosidase and dipeptidyl peptidase IV (DPP-IV) enzymes. Moreover, although D2 was inactive against these enzymes, D1 IC50 value was lower than those found for the hydrolysates. Interestingly, after electrophoretic separation, D1 mannose-linked peptides showed the highest α-glucosidase inhibitory activity, while non-glycosylated peptides had the highest DPP-IV inhibitory activity. Kinetic analyses showed a non-competitive mechanism in both cases. After peptide identification, GILFVGSGVSGGEEGAR and IINEPTAAAIAYGLDK showed the highest in silico anti-diabetic activities among mannose-linked and non-glycosylated peptides, respectively (AntiDMPpred score: 0.70 and 0.77). Molecular docking also indicated that these peptides act as non-competitive inhibitors. Finally, an ex vivo model of mouse jejunum organoids was used to study the effect of D1 on the expression of intestinal epithelial genes related to diabetes. The reduction of the expression of genes that codify lactase, sucrase-isomaltase and glucose transporter 2 was observed, as well as an increase in the expression of Gip (glucose-dependent insulinotropic peptide) and Glp1 (glucagon-like peptide 1). This is the first report to evaluate the anti-diabetic effect of BSY peptides in mouse jejunum organoids. |
publishDate |
2024 |
dc.date.none.fl_str_mv |
2024-03 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://hdl.handle.net/11336/233450 Aquino, Marilín Estefanía; Drago, Silvina Rosa; Sánchez de Medina, Fermín; Martínez Augustin, Olga; Cian, Raúl Esteban; Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion; Royal Society of Chemistry; Food & Function; 15; 7; 3-2024; 3778-3790 2042-6496 2042-650X CONICET Digital CONICET |
url |
http://hdl.handle.net/11336/233450 |
identifier_str_mv |
Aquino, Marilín Estefanía; Drago, Silvina Rosa; Sánchez de Medina, Fermín; Martínez Augustin, Olga; Cian, Raúl Esteban; Anti-diabetic properties of brewer's spent yeast peptides: In vitro, in silico and ex vivo study after simulated gastrointestinal digestion; Royal Society of Chemistry; Food & Function; 15; 7; 3-2024; 3778-3790 2042-6496 2042-650X CONICET Digital CONICET |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/url/https://pubs.rsc.org/en/content/articlelanding/2024/fo/d3fo04040b info:eu-repo/semantics/altIdentifier/doi/10.1039/D3FO04040B |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess https://creativecommons.org/licenses/by-nc/2.5/ar/ |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by-nc/2.5/ar/ |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/pdf application/pdf |
dc.publisher.none.fl_str_mv |
Royal Society of Chemistry |
publisher.none.fl_str_mv |
Royal Society of Chemistry |
dc.source.none.fl_str_mv |
reponame:CONICET Digital (CONICET) instname:Consejo Nacional de Investigaciones Científicas y Técnicas |
reponame_str |
CONICET Digital (CONICET) |
collection |
CONICET Digital (CONICET) |
instname_str |
Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.name.fl_str_mv |
CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas |
repository.mail.fl_str_mv |
dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar |
_version_ |
1842269806626078720 |
score |
13.13397 |